ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

M. D. Anderson Buys Record System For In-Patient Services From Atlanta Firm.

May 4, 2001

Klausner Unveils New NCI Structure, Aims To Change Institute’s “Ethos”

August 11, 1995

Specialists List 15 Criteria For Choosing Health Insurance.

January 14, 2000

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011